Cite
HARVARD Citation
Bonthapally, V. et al. (n.d.). Brentuximab vedotin compared with other therapies in relapsed/refractory Hodgkin lymphoma post autologous stem cell transplant: median overall survival meta-analysis. Current medical research and opinion. pp. 1377-1389. [Online].